TRAM Snapshot of App at Pub for Oppostn

BIGFOOT UNITY

Bigfoot Biomedical, Inc.

TRAM Snapshot of App at Pub for Oppostn

Trademark Snap Shot Publication Stylesheet
(Table presents the data on Publication Approval)

OVERVIEW

SERIAL NUMBER 88333195 FILING DATE 03/10/2019
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY NICHOLSON, KERRY A.
L.O. ASSIGNED N20-NOT FOUND

PUB INFORMATION

RUN DATE 11/02/2021
PUB DATE 07/23/2019
STATUS 819-SU - REGISTRATION REVIEW COMPLETE
STATUS DATE 11/01/2021
LITERAL MARK ELEMENT BIGFOOT UNITY

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) YES 1 (a) NO
1 (b) YES 1 (b) NO 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT BIGFOOT UNITY
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Bigfoot Biomedical, Inc.
ADDRESS 1820 McCarthy Blvd.
Milpitas, CA 95035
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 009
          DESCRIPTION TEXT Downloadable mobile application used in conjunction with blood glucose meter and insulin delivery devices for management of diabetes including, capturing, measuring, monitoring, and tracking blood glucose, predicting blood glucose levels, providing recommendations for insulin dosage requirements, and controlling medicament delivery in the field of diabetes management; downloadable computer software for use by healthcare providers and patients with diabetes for use in the collection, display, transmission, management, monitoring, tracking, and sharing of health and medical information for management of diabetes
INTERNATIONAL CLASS 010
          DESCRIPTION TEXT Medical devices for use in managing diabetes, namely, replacement caps for insulin injection devices capable of capturing, measuring, tracking, and monitoring insulin dosage amounts; medical test kits for managing diabetes consisting of blood glucose meters, pen cap with embedded software for collecting time and dosage data, pen cap charging device, single-use pen needles for injecting insulin, continuous glucose monitoring sensor for monitoring glucose levels, test strips, lancing device, lancets, alcohol pads, and carrying case
INTERNATIONAL CLASS 035
          DESCRIPTION TEXT Subscription mail order services in the field of diabetes supplies delivered to the home
INTERNATIONAL CLASS 042
          DESCRIPTION TEXT Software as a service (SAAS) services featuring software for facilitating the remote access and interoperability of blood glucose meters and mobile applications for data management, monitoring, tracking, sharing, analyzing and viewing of health and medical information for the management of diabetes

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 009 FIRST USE DATE 06/28/2021 FIRST USE IN COMMERCE DATE 07/01/2021 CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 010 FIRST USE DATE 07/09/2021 FIRST USE IN COMMERCE DATE 07/09/2021 CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 035 FIRST USE DATE 08/27/2021 FIRST USE IN COMMERCE DATE 08/27/2021 CLASS STATUS 6-ACTIVE
INTERNATIONAL CLASS 042 FIRST USE DATE 07/01/2021 FIRST USE IN COMMERCE DATE 07/01/2021 CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
11/02/2021 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED 047
11/01/2021 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED 046
10/06/2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 045
10/05/2021 SUPC I STATEMENT OF USE PROCESSING COMPLETE 044
10/05/2021 EX4G S EXTENSION 4 GRANTED 043
09/17/2021 EXT4 S EXTENSION 4 FILED 042
09/17/2021 IUAF S USE AMENDMENT FILED 041
09/21/2021 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL 040
09/17/2021 EEXT I TEAS EXTENSION RECEIVED 039
09/17/2021 EISU I TEAS STATEMENT OF USE RECEIVED 038
02/23/2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 037
02/19/2021 EX3G S EXTENSION 3 GRANTED 036
02/19/2021 EXT3 S EXTENSION 3 FILED 035
02/19/2021 EEXT I TEAS EXTENSION RECEIVED 034
09/02/2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 033
08/31/2020 EX2G S EXTENSION 2 GRANTED 032
08/31/2020 EXT2 S EXTENSION 2 FILED 031
08/31/2020 EEXT I TEAS EXTENSION RECEIVED 030
02/26/2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 029
02/25/2020 EX1G S EXTENSION 1 GRANTED 028
02/17/2020 EXT1 S EXTENSION 1 FILED 027
02/25/2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL 026
02/17/2020 EEXT I TEAS EXTENSION RECEIVED 025
12/06/2019 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED 024
12/06/2019 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED 023
12/06/2019 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED 022
12/06/2019 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED 021
09/17/2019 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 020
07/23/2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 019
07/23/2019 PUBO A PUBLISHED FOR OPPOSITION 018
07/03/2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 017
06/18/2019 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED 016
06/17/2019 ALIE A ASSIGNED TO LIE 015
06/04/2019 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 014
06/03/2019 XAEC I EXAMINER'S AMENDMENT ENTERED 013
06/03/2019 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED 012
06/03/2019 GNEA O EXAMINERS AMENDMENT E-MAILED 011
06/03/2019 CNEA R EXAMINERS AMENDMENT -WRITTEN 010
05/30/2019 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED 009
05/29/2019 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE 008
05/29/2019 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED 007
05/26/2019 GPRN O NOTIFICATION OF PRIORITY ACTION E-MAILED 006
05/26/2019 GPRA F PRIORITY ACTION E-MAILED 005
05/26/2019 CPRA R PRIORITY ACTION WRITTEN 004
05/19/2019 DOCK D ASSIGNED TO EXAMINER 003
03/28/2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
03/13/2019 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Jana L. France, Esq.
CORRESPONDENCE ADDRESS Jana L. France, Esq.
FisherBroyles, LLP
4505 Jewel Lane North
Plymouth, MN 55446
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Bigfoot Biomedical, Inc.
ADDRESS 1561 Buckeye Drive
Milpitas, CA 95035
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

TRAM Snapshot of App at Pub for Oppostn [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed